3
11
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T73415 |
Miclxin
DS37262926 |
Wnt/beta-catenin | Cytoskeletal Signaling; Stem Cells |
Miclxin (DS37262926) 是一种新型MIC60抑制剂,通过β-连环蛋白突变肿瘤细胞中的线粒体应激诱导细胞凋亡。Miclxin 是突变体 β-catenin 的有效抑制剂,参与 Wnt 信号通路。Miclxin 可诱导 β-catenin 依赖性凋亡,导致线粒体损伤,线粒体膜丢失。Miclxin 具有抗肿瘤活性,通过靶向 MIC60 杀伤肿瘤。 | |||
T23724 |
Amiclenomycin
BRN 5525177,BRN-5525177,NSC 246130,NSC-246130,BRN5525177 |
||
Amiclenomycin is an antibiotic. It has activity against mycobacterium. | |||
T40854 |
Imiclopazine
|
||
Imiclopazine is a phenothiazine derivative with good sedative, analgesic, antiaggressive and antiemetic effects. |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-02092 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His)
HECL,CLL-1,CD303,PRO34150,DCAL-2,CLL1,DLEC,CLECSF11,CLECSF7,... |
Human | HEK293 Cells |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 41~45 kDa and the accession number is EAW96132.1. | |||
TMPY-06865 |
CLEC12A/MICL/CLL-1 Protein, Mouse, Recombinant (His)
D230024O04,C-type lectin domain family 12, member A,Micl... |
Mouse | HEK293 Cells |
CLEC12A/MICL/CLL-1 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 25.12 kDa and the accession number is NP_808354.1. | |||
TMPK-00548 |
CLEC12A/MICL/CLL-1 Protein, Cynomolgus, Recombinant (His)
CD371,HECL,CLECSF11,CLEC12A,CD303,CLL-1,PRO34150,DLEC,DCAL2,... |
Cynomolgus | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Cynomolgus, Recombinant (His) is ... | |||
TMPK-01003 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His, Avi), Biotinylated
DCAL2,CD371,CLEC12A,CLL-1,MICL,CD303,HECL,PRO34150,... |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His, Avi), Bi... | |||
TMPK-01004 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (aa 65-265, hFc)
DCAL2,HECL,DCAL-2,DLEC,CLECSF11,CLEC12A,CD371,MICL,... |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (aa 65-265, hF... | |||
TMPK-01005 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled
DCAL-2,HECL,CLL-1,CLECSF7,CD371,CLEC12A,PRO34150,MICL |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-La... | |||
TMPK-00995 |
CLEC12A/MICL/CLL-1 Protein, Mouse, Recombinant (aa 65-267, His)
HECL,CLL1,CD371,CLL-1,CLEC12A,MICL,DCAL-2,PRO34150,... |
Mouse | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Mouse, Recombinant (aa 65-267, Hi... | |||
TMPK-01002 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (hFc & Avi), Biotinylated
HECL,DCAL-2,CD303,CLECSF7,DCAL2,CLECSF11,CLL1,CLL-1,CD371, |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (hFc & Avi), B... | |||
TMPY-06866 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (hFc)
CLECSF11,MICL,CLECSF7,DLEC,C-type lectin domain fam... |
Human | HEK293 Cells |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 50.38 kDa and the accession number is EAW96132.1. | |||
TMPK-01006 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (aa 65-265, His)
CLECSF7,CLL-1,PRO34150,CLL1,DLEC,CLEC12A,DCAL2,CLECSF11,... |
Human | HEK293 Cells |
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (aa 65-265, Hi... | |||
TMPY-06881 |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (Avi & Fc), Biotinylated
MICL,PRO34150,CLL1,DCAL-2,CD303,CLL-1,CD371,CLECSF7... |
Human | HEK293 Cells |
CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (Avi & Fc), Biotinylated is expressed in HEK293 mammalian cells with AVI and Fc tag. The predicted molecular weight is 51.61 kDa and the accession number is EAW96132.1. |